Abstract
Psoriatic arthritis (PsA) is a distinctive category of inflammatory arthritis that complicates cutaneous psoriasis. The prevalence of PsA in the general population is estimated to be between 0.3% and 1%, only slightly less common than that of rheumatoid arthritis (RA). PsA is one of the “seronegative spondyloarthropa-thies”, along with ankylosing spondylitis (AS), reactive arthritis, and the arthropathy of inflammatory bowel disease. As a seronegative disorder, PsA is not associated with autoantibodies such as rheumatoid factor or antibodies to cyclic citrullinated peptides. A variety of clinical patterns of PsA are recognized: distal joint disease, oligoarthritis, a symmetrical polyarthritis that resembles RA, and spondylitis. Some patients present with combinations of these features: e.g., oligoarthritis plus spondylitis. These clinical patterns are not necessarily stable over time. For example, distal joint disease can evolve into polyarthritis. The most common pattern of joint involvement at presentation is an asymmetric oligoarthritis. This pattern accounts for about 70% of PsA cases.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Ali Y, Tom BDM, Schentag CT, Farewell VT, Gladman DD. Improved survival in psoriatic arthritis (PsA) with calendar time. Arthritis Rheum 2007; 56:2708–2714
Bond SJ, Farewell VT, Schentag CT, Gladman DD. Predictors for radiological damage in Psoriatic Arthritis: Results from a single centre. Ann Rheum Dis 2007; 66:370–376
Brockbank J, Stein M, Schentag CT, Gladman DD. Dactylitis in psori-atic arthritis (PsA): A marker for disease severity? Ann Rheum Dis 2005; 62:188–190
Bruce IN, Schentag C, Gladman DD. Hyperuricemia in psoriatic arthritis (PsA) does not reflect the extent of skin involvement. J Clin Rheumatol 2000; 6:6–9
Buskila D, Langevitz P, Gladman DD, Urowitz S, Smythe H. Patients with rheumatoid arthritis are more tender than those with psoriatic arthritis. J Rheumatol 1992; 19:1115–1119
Cohen, MR, Reda, DJ, Clegg, DO. Baseline relationships between psoriasis and psoriatic arthritis: Analysis of 221 patients with active psoriatic arthritis. J Rheumatol 1999; 26:1752–1756
Coulton BL, Thomson K, Symmons DP, Popert AJ. Outcome in patients hospitalised for psoriatic arthritis. Clin Rheumatol 1989; 8:261–265
Eastmond CJ, Wright V. The nail dystrophy of psoriatic arthritis. Ann Rheum Dis 1979; 38:226–228
Eder L, Zisman D, Barzilai M, Laor A, Rahat M, Rozenbaum M, et al Subclinical atherosclerosis in psoriatic arthritis: A case-control study. J Rheumatol 2008; 35:877–782
Elkayam O, Ophir J, Yaron M, Caspi D. Psoriatic arthritis: Interrelationships between skin and joint manifestations related to onset, course and distribution. Clin Rheumatol 2000;19: 301–305
Ferná ndez-Sueiro JL, Willisch A, Pinto J, et al Prevalence and location of enthesitis in ankylosing spondylitis and psoriatic arthritis. Ann Rheum Dis 2007; 66(Suppl II):99
Gelfand JM, Gladman DD, Mease PJ, et al Epidemiology of psoriatic arthritis in the United States population. J Amer Acad Dermatol 2005; 53:573–577
Gladman DD. Clinical aspects of spondyloarthropathies. Am J Med Sci 1998; 316:234–238
Gladman DD. Axial disease in psoriatic arthritis. Curr Rheumatol Rep 2007; 9:455–460
Gladman DD, Anhorn KB, Schachter RK, Mervart H. HLA antigens in psoriatic arthritis. J Rheumatol 1986; 13:586–592
Gladman DD, Shuckett R, Russell ML, Thorne JC, Schachter RK. Psoriatic arthritis — clinical and laboratory analysis of 220 patients. Quart J Med 1987; 62:127–141
Gladman DD, Brubacher B, Buskila D, Langevitz P, Farewell VT. Differences in the expression of spondyloarthropathy: A comparison between ankylosing spondylitis and psoriatic arthritis. Genetic and gender effects. Clin Invest Med 1993; 16:1–7
Gladman DD, Farewell VT, Husted J, Wong K. Mortality studies in psoriatic arthritis. Results from a single centre. II. Prognostic indicators for mortality. Arthritis Rheum 1998; 41:1103–1110
Gladman DD, Ang M, Su L, Tom BDM, Schentag CT, Farewell VT. Cardiovascular morbidity in psoriatic arthritis (PsA). Ann Rheum Dis Online. Accessed December 8, 2008
Gladman DD, Helliwell PS, Mease PJ. GRAPPA at the European League Against Rheumatism (EULAR) 2008. J Rheumatol 2009; 36:656–658
Helliwell PS. Relationship of psoriatic arthritis with the other spondy-loarthropathies. Curr Opin Rheumatol 2004; 16:344–349
Helliwell PS, Hickling P, Wright V. Do the radiological changes of classic ankylosing spondylitis differ from the changes found in the spondylitis associated with inflammatory bowel disease, psoriasis, and reactive arthritis? Ann Rheum Dis 1998; 57:135–140
Jajic J. Blue-coloured skin over involved joints in psoriatic arthritis. Clin Rheumatol 2001; 20:304–305
Jones SM, Armas JB, Cohen MG, et al Psoriatic arthritis: Outcome of disease subsets and relationship of joint disease to nail and skin disease. Br J Rheumatol 1994; 33:834–839
Kane D, Stafford L, Bresniham B, Fitzgerald O. A prospective, clinical and radiological study of early psoriatic arthritis: an early synovitis clinic experience Rheumatol 2003; 42:1460–1468
McGonagle, D. The concept of a synovio-enthesial complex and its implications for understanding joint inflammation and damage in psoriatic arthritis and beyond. Arthritis Rheum 2007; 56:8
McHugh NJ, Balachrishnan C, Jones SM. Progression of peripheral joint disease in psoriatic arthritis: A 5-yr prospective study. Rheumatology (Oxford) 2003; 42:778–783
Moll JM, Wright V. Psoriatic arthritis. Semin Arthritis Rheum 1973; 3:55–78
O'Shea FD, Chandran V, Toloza SMA, Schentag CT, Inman RD, Gladman DD. Does axial disease exhibit a different phenotype in primary ankylosing spondylitis versus psoriatic arthritis? Arthritis Rheum 2006; 54:4091
Queiro-Silva R, Torre-Alonso JC, Tinture-Eguren T, et al A polyarticu-lar onset predicts erosive and deforming disease in psoriatic arthritis. Ann Rheum Dis 2003; 62:68–70
Shbeeb M, Uramoto KM, Gibson LE, O'Fallon WM, Gabriel SE. The epidemiology of psoriatic arthritis in Olmsted County, Minnesota, USA, 1982–1991. J Rheumatol 2000; 27:1247–1250
Sokoll KB, Helliwell PS. Comparison of disability and quality of life in rheumatoid and psoriatic arthritis. J Rheumatol 2001; 28: 1842–1846
Tam LS, Shang Q, Li EK, Tomlinson B, Chu TT, Li M, et al Subclinical carotid atherosclerosis in patients with psoriatic arthritis. Arthritis Rheum 2008a; 59:1322–1331
Tam LS, Tomlinson B, Chu TT, et al Cardiovascular risk profile of patients with psoriatic arthritis compared to controls—the role of inflammation. Rheumatology (Oxford) 2008b; 47:718–723
Wright V. Rheumatism and psoriasis a re-evaluation. Am J Med 1959; 27:454–462.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2009 Springer Science+Business Media B.V.
About this chapter
Cite this chapter
Ritchlin, C., Mody, E., Mease, P., Gladman, D.D. (2009). Psoriatic Arthritis. In: Stone, J.H. (eds) A Clinician's Pearls and Myths in Rheumatology. Springer, London. https://doi.org/10.1007/978-1-84800-934-9_8
Download citation
DOI: https://doi.org/10.1007/978-1-84800-934-9_8
Publisher Name: Springer, London
Print ISBN: 978-1-84800-933-2
Online ISBN: 978-1-84800-934-9
eBook Packages: MedicineMedicine (R0)